Clinical Chemistry · 1996 · 43 citations · 5 references
Life SciencesImmunologyAutoimmunityClinical ImmunologyMonoclonal AntibodiesAntibody CharacterizationAutoantibodiesAutoantigensThyroid CancerAssayAssay SpecificityAutoantibody AssaysAutoimmune Thyroid Disease TestingInterferenceThyroglobulin AntibodiesThyroid AutoantibodiesThyroid Autoimmunity
Five monoclonal antibodies (MAbs) directed against antigenic domains on thyroglobulin (Tg) not recognized by most anti-Tg human autoantibodies (aAbs) have been used to develop an improved IRMA for serum Tg with a limit of detection of 0.2 micrograms/L. Samples are incubated for 3 h in tubes coated with four anti-Tg MAbs. After washing, the tubes are incubated with the tracer MAb for 20 h at room temperature. Dilution and reproducibility tests demonstrated assay reliability. Tests performed on samples with (n = 361) or without (n = 283) aAbs showed that the TG IRMA Pasteur is largely independent of the marked interference generally caused by aAbs. These results were confirmed with an extended population of 2759 samples. For a cutoff of 1 micrograms/L, sensitivity and specificity were 0.97 and 1, respectively, in a follow-up of differentiated thyroid carcinoma in patients treated by total thyroidectomy.
5
Martine Piechaczyk, Majida Bouanani, Sarra Salhi et al. · Clinical Immunology and Immunopathology · 1987 · 79 citations